IRIS
SALTARELLA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.799
EU - Europa 353
AS - Asia 136
SA - Sud America 3
OC - Oceania 1
Totale 2.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.798
SE - Svezia 147
CN - Cina 102
IT - Italia 85
VN - Vietnam 23
FR - Francia 22
BE - Belgio 21
FI - Finlandia 21
GB - Regno Unito 20
DE - Germania 19
IN - India 8
IE - Irlanda 5
PL - Polonia 5
CL - Cile 3
HU - Ungheria 2
UA - Ucraina 2
AU - Australia 1
BY - Bielorussia 1
CA - Canada 1
IR - Iran 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.292
Salva come PNG Salva come JPEG
Città #
Chandler 242
Fairfield 229
Ashburn 187
Woodbridge 147
Nyköping 138
Seattle 115
Cambridge 106
Ann Arbor 104
Wilmington 102
Houston 96
New York 62
Beijing 44
Bari 39
Lawrence 32
Roxbury 31
Nanjing 25
Dong Ket 23
Brussels 21
Brooklyn 18
Des Moines 17
Helsinki 16
San Diego 15
Dearborn 14
Washington 13
Inglewood 12
Marseille 11
Jacksonville 8
Paris 8
Princeton 8
Los Angeles 6
Rome 6
Dublin 5
Jiaxing 5
London 5
Boardman 4
Grafing 4
Pune 4
Radomsko 4
Barletta 3
Chicago 3
Hebei 3
Jinan 3
Kunming 3
Nanchang 3
Redwood City 3
Suri 3
Augusta 2
Budapest 2
Changsha 2
Guangzhou 2
Putignano 2
Reggio Calabria 2
Santiago 2
Tianjin 2
Acton 1
Ardabil 1
Baotou 1
Bitetto 1
Bratislava 1
Cincinnati 1
Ergolding 1
Falkenstein 1
Florence 1
Gurgaon 1
Hefei 1
Islington 1
Kilburn 1
Kyiv 1
Luxembourg 1
Markham 1
Medesano 1
Milan 1
Minsk 1
Modugno 1
Nagold 1
Ningbo 1
Norwalk 1
Nuremberg 1
Radeberg 1
Redmond 1
San Francisco 1
San Mateo 1
Sankt Augustin 1
Shenyang 1
Shenzhen 1
Southend 1
Southwark 1
Sydney 1
Taizhou 1
Talsano 1
Tamm 1
Tappahannock 1
Tokyo 1
Trani 1
Vimodrone 1
Totale 2.007
Salva come PNG Salva come JPEG
Nome #
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 126
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 116
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 111
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 109
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 108
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 105
Identify multiple myeloma stem cells: Utopia? 103
null 101
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 99
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 96
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 93
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 82
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 80
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 79
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 77
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 76
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 67
Bortezomib treatment modulates autophagy in multiple myeloma 66
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 59
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 55
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 48
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 48
null 44
null 43
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 40
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 36
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 36
null 31
null 30
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 30
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 27
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 25
Antiangiogenic drugs as chemosensitizers in hematological tumors 24
The “angiogenic switch” from MGUS to MM: what about the Notch role? 23
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 22
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 22
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 21
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 20
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis 18
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 18
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 11
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 11
Drug repurposing in skeletal muscle ion channelopathies 10
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 10
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 9
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 9
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 8
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 8
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 7
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 6
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 6
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 2
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 1
Totale 2.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019127 0 0 0 0 0 0 0 0 0 35 47 45
2019/2020569 55 31 17 49 46 48 56 68 62 62 49 26
2020/2021519 14 30 34 45 100 30 39 47 25 71 38 46
2021/2022282 20 21 3 11 9 18 18 16 23 22 40 81
2022/2023610 54 97 47 49 62 74 12 79 90 11 19 16
2023/2024295 16 34 19 23 50 121 8 12 5 7 0 0
Totale 2.512